Compounds > sorafenib

Page last updated: 2024-09-05

sorafenib and Keratosis

sorafenib has been researched along with Keratosis in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Cao, J; Chen, X; Du, J; He, Q; Luo, P; Ma, S; Xu, Z; Yan, H; Yang, B; Zeng, S; Zhang, X; Zhang, Y; Zhao, Z; Zhu, Y	1
Di Micoli, A; Frigerio, M; Santi, V; Trevisani, F	1
Burkemper, NM; Chappell, JA; Semchyshyn, N	1
Avril, MF; Barete, S; Billemont, B; Blanchet, B; Carlotti, A; Francès, C; Franck, N; Goldwasser, F; Moguelet, P; Ropert, S	1
Desai, A; Lacouture, ME; Laumann, AE; Petronic-Rosic, V; Ratain, MJ; Soltani, K; Stadler, WM	1

Other Studies

5 other study(ies) available for sorafenib and Keratosis

Article	Year
s-HBEGF/SIRT1 circuit-dictated crosstalk between vascular endothelial cells and keratinocytes mediates sorafenib-induced hand-foot skin reaction that can be reversed by nicotinamide. Cell research, 2020, Volume: 30, Issue:9 Topics: Aged; Aged, 80 and over; Animals; Disease Models, Animal; Endothelial Cells; Female; Foot; HaCaT Cells; Hand; Heparin-binding EGF-like Growth Factor; Humans; Keratinocytes; Keratosis; Male; Mice, Inbred ICR; Middle Aged; Mitogen-Activated Protein Kinase 9; Models, Biological; Niacinamide; Phosphorylation; Protein Stability; Sirtuin 1; Skin; Sorafenib	2020
Hyperkeratosis of nipple skin during sorafenib treatment. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2009, Volume: 41, Issue:8 Topics: Aged; Antineoplastic Agents; Benzenesulfonates; Breast Diseases; Carcinoma, Hepatocellular; Humans; Keratosis; Liver Neoplasms; Male; Niacinamide; Nipples; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Sorafenib	2009
Localized dyskeratotic plaque with milia associated with sorafenib. Journal of drugs in dermatology : JDD, 2009, Volume: 8, Issue:6 Topics: Acantholysis; Benzenesulfonates; Carcinoma, Hepatocellular; Diabetes Mellitus; Drug Eruptions; Hepatitis B; Humans; Keratosis; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Sorafenib	2009
Spiny follicular hyperkeratosis eruption: a new cutaneous adverse effect of sorafenib. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Nov-01, Volume: 28, Issue:31 Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Benzenesulfonates; Drug Eruptions; Female; Folliculitis; Humans; Keratosis; Male; Middle Aged; Neoplasms; Niacinamide; Phenylurea Compounds; Protein Kinases; Pyridines; Skin; Sorafenib	2010
Inflammation of actinic keratoses subsequent to therapy with sorafenib, a multitargeted tyrosine-kinase inhibitor. Clinical and experimental dermatology, 2006, Volume: 31, Issue:6 Topics: Antineoplastic Agents; Benzenesulfonates; Drug Eruptions; Humans; Keratosis; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Photosensitivity Disorders; Protein Kinase Inhibitors; Pyridines; Sorafenib	2006